1.Zhao YC, Qiu RR, Wang Z, Li YY, Yang X, Li YL, Shen XH, Liu Y, Chen ZQ*, You QS*, Shi QH*, Single-Cell Sequencing-Guided Annotation of Rare Tumor Cells for Deep Learning-Based Cytopathologic Diagnosis of Early Lung Cancer, Adv. Sci. 2025, 2416921.

2.Wang Z, Zhao YY, Shen XH, Zhao YC, Zhang ZY, Yin HM, Zhao XJ*, Liu HT*, Shi QH*, Single-cell genomics-based molecular algorithm for early cancer detection, Anal. Chem. 2022, 94, 2607–2614.

3.Chen J, Yang YB, Wang Z, Shen XH, Zhang ZY, Wang CY, Xu HM*, Shi QH*, A multicancer malignant pleural effusion diagnostic test using hexokinase 2 and single-cell sequencing, Clin. Chem. 2022, 68, 680-690.

4.Wang Z, Chen J, Yang L, Cao MZ, Yu YL, Zhang RL, Quan H, Jiang Q, Hua YQ, Wei W, Lu PH*, Wu J*, Shi QH*, Single-cell sequencing-enabled hexokinase 2 assay for noninvasive bladder cancer diagnosis and screening by detecting rare malignant cells in urine, Anal. Chem. 2020, 92, 16284–16292.

5.Li ZM, Wang Z, Tang Y, Lu X, Chen J, Dong Y, Wu BJ, Wang CY, Yang L, Guo ZL, Xue M, Lu S*, Wei W*, Shi QH*, Liquid Biopsy-Based Single-Cell Metabolic Phenotyping of Lung Cancer Patients for Informative Diagnostics, Nat. Commun. 2019, 3856.

6.Tang Y, Wang Z, Li ZM, Kim J, Deng YL, Li Y, Heath JR, Wei W*, Lu S*, Shi QH*, High-throughput screening of rare metabolically active tumor cells in pleural effusion and peripheral blood of lung cancer patients, Proc. Natl. Acad. Sci. USA, 2017,114, 2544-2549.